1.Studies on relationship between recurrent vulvovaginal candidiasis and personal behavior and life style
Chinese Journal of General Practitioners 2005;0(09):-
Objective To investigate the relationship between recurrent vulvovaginal candidiasis (RVVC) and personal behavior and life style.Method Seventy-two patients with RVVC and 72 normal healthy women were studied with questionnaire by case-control design.Results Analysis by univariate unconditional logistic regression showed that contraception (OR=0.266), frequently changing and washing one’s underpants (OR=0.378), vaginal douche (OR=1.881), sharing bath towel with others (OR=1.872), sharing underpants with others (OR=6.163) and cigarette smoking or passive smoking (OR=3.164) were significantly associated with RVVC at significance level of 0.05. Analysis by multivariate unconditional logistic regression showed that contraception (OR=0.219), frequency of sexual intercourse (OR=1.806), use of sanitary napkins without guaranteed quality (OR=1.844), self-vaignial douche (OR=1.911) and cigarette smoking or passive smoking (OR=2.875) were associated with RVVC at significance level of 0.15.Conclusions Poor personal hygiene and unhealthy life style were important factors attributed to RVVC. It is suggested to promote correct personal hygienic behavior and healthy life-style in women by health education in order to reduce RVVC.
2.Application of lfexible ureteroscopy in upper urinary tract hematuria of computed tomography urography negative (10 cases)
Changwen WU ; Anyi ZHU ; Zimin SHI ; Cheng CHENG ; Zhengdong HONG ; Shuangquan LIN
China Journal of Endoscopy 2017;23(1):70-73
Objective To investigate and evaluate the clinical signiifcance of lfexible ureteroscopy in computed tomography urography negative patients with upper urinary tract hematuria. To improve the diagnostic rate of patients with upper urinary tract hematuria. Methods We retrospectively reviewed the cases of 10 computed tomography urography negative patients with upper urinary tract hematuria. The age ranges from 38 to 75 years old, and the average of them is 45.2 years old. The patients consist of 7 male patients and 3 female patients. Among them, 4 cases were on the left upper urinary tract cases, 6 cases were right upper urinary tract. All patients received lfexible ureteroscopy to conifrm the diagnosis and take the relevant treatment. Results In the total of 10 patients, 3 patients (30%) were diagnosed with tumors of renal pelvis, a renal arteriovenous ifstula was found in 1 case (10%), 3 patients (30%) were considered non-specific inflammation, other 3 patients (30%) had no obvious abnormalities. Conclusions Flexible ureteroscopy has significantly clinical diagnosis in computed tomography urography negative patients with upper urinary tract hematuria.
3.A Case of Refractory Childhood Glaucoma Secondary to Weill-Marchesani Syndrome: Management with Combined CO2 Laser-Assisted Sclerectomy Surgery and Trabeculectomy
Zhang YANG ; Bian AILING ; Liang ANYI ; Mo FEI ; Cheng GANGWEI
Chinese Medical Sciences Journal 2022;37(2):159-163
A 2-year-old girl was diagnosed as Weill-Marchesani syndrome with typical systemic features of short stature, short and stubby hands and feet, language disorders and mental retardation. He developed bilateral angle closure glaucoma, ectopia lentis and suffered visual loss from the ocular features of Weill-Marchesani syndrome. The child was successfully treated by combined CO2 laser-assisted sclerectomy surgery and trabeculectomy.
4.Vaccination against coronavirus disease 2019 in patients with pulmonary hypertension: A national prospective cohort study
Xiaohan WU ; Jingyi LI ; Jieling MA ; Qianqian LIU ; Lan WANG ; Yongjian ZHU ; Yue CUI ; Anyi WANG ; Cenjin WEN ; Luhong QIU ; Yinjian YANG ; Dan LU ; Xiqi XU ; Xijie ZHU ; Chunyan CHENG ; Duolao WANG ; Zhicheng JING
Chinese Medical Journal 2024;137(6):669-675
Background::Coronavirus disease 2019 (COVID-19) has potential risks for both clinically worsening pulmonary hypertension (PH) and increasing mortality. However, the data regarding the protective role of vaccination in this population are still lacking. This study aimed to assess the safety of approved vaccination for patients with PH.Methods::In this national prospective cohort study, patients diagnosed with PH (World Health Organization [WHO] groups 1 and 4) were enrolled from October 2021 to April 2022. The primary outcome was the composite of PH-related major adverse events. We used an inverse probability weighting (IPW) approach to control for possible confounding factors in the baseline characteristics of patients.Results::In total, 706 patients with PH participated in this study (mean age, 40.3 years; mean duration after diagnosis of PH, 8.2 years). All patients received standardized treatment for PH in accordance with guidelines for the diagnosis and treatment of PH in China. Among them, 278 patients did not receive vaccination, whereas 428 patients completed the vaccination series. None of the participants were infected with COVID-19 during our study period. Overall, 398 patients received inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, whereas 30 received recombinant protein subunit vaccine. After adjusting for baseline covariates using the IPW approach, the odds of any adverse events due to PH in the vaccinated group did not statistically significantly increase (27/428 [6.3%] vs. 24/278 [8.6%], odds ratio = 0.72, P = 0.302). Approximately half of the vaccinated patients reported at least one post-vaccination side effects, most of which were mild, including pain at the injection site (159/428, 37.1%), fever (11/428, 2.6%), and fatigue (26/428, 6.1%). Conclusions::COVID-19 vaccination did not significantly augment the PH-related major adverse events for patients with WHO groups 1 and 4 PH, although there were some tolerable side effects. A large-scale randomized controlled trial is warranted to confirm this finding. The final approval of the COVID-19 vaccination for patients with PH as a public health strategy is promising.